Harnessing The Power Of The Cloud For Life Sciences

Posted by Lewis Sparks on in Life Sciences 0 Comment

data

The very nature of innovation has undergone a drastic change over the past decade. One of the major factors behind this change is the way which we handle huge volumes of data. Digital data collection and analysis has transformed industries across all verticals. In Research dependent industries like Pharmaceutical and Biotech, the reliability on data has always been vital. However, until very recently, the huge potential of data had not been explored. However, All that’s changing with the help of cloud software.

What exactly is the Cloud?
Unlike conventional software, cloud software is not installed on local systems. It is rather deployed on a common server and is used by several organizations collectively. This offers manifold benefits. With the cloud, the time for installing and updating new software is within minutes rather than taking weeks like with conventional software. The best benefit of cloud software is reduced operational cost. Instead of shelling out thousands of dollars to buy software, you can use it for a fraction of the cost. Also, updates and newer improvements can be made on the run, benefitting the end users immensely.

How Cloud Software Helps in the Life Sciences?
Just like all industries benefit from Cloud based software, life sciences too can benefit tremendously from it. Seamless collaboration, automation of experiments, highly advanced analytics and higher operational efficiency is a few of the main benefits of cloud software in the life sciences.

The Future is in the Cloud
Speed matters a lot when it comes to life sciences. Cloud based software ensures that the time to complete experiments is kept to a minimum. This is highly imperative to gain the edge over competitors. Cloud based software also offers the potential to explore artificial intelligence and machine aided learning. So, life sciences firms are gearing up to take their experiments to the cloud.

Met Gala – A Union Of Couture Fashion & Technology

Posted by Lewis Sparks on in Science & Technology 0 Comment

fashion

The annual Met Gala was held recently and the theme of this year’s exhibition is “Manus X Machina”, rather fashion trends in the age of Digital Technology. The Met Gala often dubbed as the Oscars of the Fashion World and is held to commemorate the opening of the latest exhibit at the Metropolitan Museum. This year’s theme was chosen to examine the relationship of fashion and technology and to bridge the gap between hand-crafted designs and machine made designs.

The event featured around 170 designs that were ready to wear and exhibited the trends of haute couture right from the turn of the century to the new millennium. Andrew Bolton, the curator of the costume institute looked to put an end to the long raging debate, “Is fashion an Art?” through this event. He stated that fashion is undeniably an art though it is quite functional. He says that just like art, fashion is significant and highly relevant.

There were several popular designers who displayed their pieces proudly. Some of them were Alexander McQueen, Yves Saint Laurent and Madame Gres. Iris Van Herpen, the Dutch Fashion Designer who created the first 3D printed garment was also a part of the echelon.

Hope In The Horizon – Zika Vaccine In The Trials

Posted by Lewis Sparks on in Health 0 Comment

science

Scientists are currently involved in a research for a vaccine against Zika and if all go well, then the vaccine could be available as early as 2018. Anthony Fauci, the Director of NIAID ( National Institute of Allergy and Infectious Diseases) in Maryland made this announcement earlier in the day. The NIAID has plans of doing trial runs of a vaccine developed in its labs on around 80 volunteers during September, this year.

If the vaccine is found to be safe and has the capability to simulate immune responses, then NIAID has further plans to launch it in the first quarter of next year. However, it is to be noted that this launch will be limited to countries that have a high rate of infection of this deadly disease.

There are several factors that will determine the success of this vaccine. Including the rate at which Zika is spread in the communities involved in the study. Also, the efficiency of a vaccine can be rightly measured only when there is a marked difference between vaccinated and unvaccinated people. However, this is rarely possible in reality.

Yet, the Vaccine offers hope to large number of communities that are gripped by this deadly disease.